about
Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry.5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.Chronic lymphocytic leukaemia: current first-line therapy.Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012.Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Emerging therapy for chronic lymphocytic leukaemia.
@en
type
label
Emerging therapy for chronic lymphocytic leukaemia.
@en
prefLabel
Emerging therapy for chronic lymphocytic leukaemia.
@en
P2093
P2860
P1476
Emerging therapy for chronic lymphocytic leukaemia.
@en
P2093
Finbarr E Cotter
John Gribben
Rebecca L Auer
P2860
P304
P356
10.1111/J.1365-2141.2007.06877.X
P407
P577
2007-10-24T00:00:00Z